Yahong Peng

1.2k total citations
34 papers, 815 citations indexed

About

Yahong Peng is a scholar working on Epidemiology, Physiology and Immunology. According to data from OpenAlex, Yahong Peng has authored 34 papers receiving a total of 815 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 5 papers in Physiology and 5 papers in Immunology. Recurrent topics in Yahong Peng's work include Pneumonia and Respiratory Infections (21 papers), Respiratory viral infections research (13 papers) and Pneumocystis jirovecii pneumonia detection and treatment (10 papers). Yahong Peng is often cited by papers focused on Pneumonia and Respiratory Infections (21 papers), Respiratory viral infections research (13 papers) and Pneumocystis jirovecii pneumonia detection and treatment (10 papers). Yahong Peng collaborates with scholars based in United States, United Kingdom and Japan. Yahong Peng's co-authors include William C. Gruber, Daniel A. Scott, Kathrin U. Jansen, Wendy Watson, Ingrid L. Scully, Michael W. Pride, Christopher R. Lines, Jeffrey Sevigny, Peter C. Giardina and Nzeera Ketter and has published in prestigious journals such as Neurology, PEDIATRICS and Clinical Infectious Diseases.

In The Last Decade

Yahong Peng

32 papers receiving 792 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yahong Peng United States 15 407 213 133 97 89 34 815
Ruth Kandel United States 11 222 0.5× 165 0.8× 127 1.0× 37 0.4× 47 0.5× 18 757
R. Risser United States 15 181 0.4× 232 1.1× 37 0.3× 65 0.7× 188 2.1× 32 931
Anu Gupta India 14 116 0.3× 95 0.4× 121 0.9× 58 0.6× 110 1.2× 89 581
Albert M. Anderson United States 17 242 0.6× 71 0.3× 369 2.8× 47 0.5× 37 0.4× 56 900
Marie Grill United States 12 103 0.3× 54 0.3× 187 1.4× 61 0.6× 190 2.1× 44 797
Aryun Kim South Korea 20 286 0.7× 85 0.4× 163 1.2× 38 0.4× 65 0.7× 62 1.3k
Lawrence Ku United States 12 113 0.3× 109 0.5× 34 0.3× 130 1.3× 36 0.4× 28 595
Gabriel Westman Sweden 17 354 0.9× 79 0.4× 208 1.6× 24 0.2× 31 0.3× 41 826
Jianjun Wang China 18 258 0.6× 74 0.3× 37 0.3× 95 1.0× 48 0.5× 60 870

Countries citing papers authored by Yahong Peng

Since Specialization
Citations

This map shows the geographic impact of Yahong Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yahong Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yahong Peng more than expected).

Fields of papers citing papers by Yahong Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yahong Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yahong Peng. The network helps show where Yahong Peng may publish in the future.

Co-authorship network of co-authors of Yahong Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Yahong Peng. A scholar is included among the top collaborators of Yahong Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yahong Peng. Yahong Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martinón‐Torres, Federico, James Trammel, Yahong Peng, et al.. (2025). A phase 3 study of 20-valent pneumococcal conjugate vaccine in healthy toddlers previously vaccinated in infancy with 13-valent pneumococcal conjugate vaccine. Vaccine. 53. 126931–126931.
2.
Senders, Shelly, Allison Thompson, Mark Cutler, et al.. (2025). Immunogenicity and safety of concomitant vaccines given with 20-valent pneumococcal conjugate vaccine in healthy infants. Vaccine. 68. 127916–127916.
3.
Peng, Yahong, et al.. (2024). A phase 3 randomized study to evaluate safety and immunogenicity of 20-valent pneumococcal conjugate vaccine in healthy Japanese infants. International Journal of Infectious Diseases. 141. 106942–106942. 2 indexed citations
4.
Haranaka, Miwa, Joon Young Song, Kuo‐Chin Huang, et al.. (2024). A phase 3 randomized trial of the safety and immunogenicity of 20-valent pneumococcal conjugate vaccine in adults ≥ 60 years of age in Japan, South Korea, and Taiwan. Vaccine. 42(5). 1071–1077. 6 indexed citations
5.
Senders, Shelly, Nicola P. Klein, Allison Thompson, et al.. (2024). A Phase Three Study of the Safety and Immunogenicity of a Four-dose Series of 20-Valent Pneumococcal Conjugate Vaccine in Healthy Infants. The Pediatric Infectious Disease Journal. 43(6). 596–603. 21 indexed citations
6.
Peng, Yahong, et al.. (2024). Safety of a 4-Dose 20-Valent Pneumococcal Conjugate Vaccine Series in Infants: A Randomized Trial. PEDIATRICS. 154(5). 1 indexed citations
7.
8.
Cannon, Kevin, José F. Cardona, Kari Yacisin, et al.. (2023). Safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine coadministered with quadrivalent influenza vaccine: A phase 3 randomized trial. Vaccine. 41(13). 2137–2146. 12 indexed citations
9.
Gessner, Bradford D., Luis Jódar, Yahong Peng, et al.. (2023). Safety and immunogenicity of a multivalent pneumococcal conjugate vaccine given with 13-valent pneumococcal conjugate vaccine in healthy infants: A phase 2 randomized trial. Human Vaccines & Immunotherapeutics. 19(2). 2245727–2245727. 3 indexed citations
10.
Thompson, Allison, Ingrid L. Scully, Peter C. Giardina, et al.. (2023). 1728. Immune Responses to Cross-Reactive Serotypes 6C and 15C After 20-Valent Pneumococcal Conjugate Vaccine in Infants. Open Forum Infectious Diseases. 10(Supplement_2). 3 indexed citations
11.
Sabharwal, Charu, Vani Sundaraiyer, Yahong Peng, et al.. (2022). Immunogenicity of a 20-valent pneumococcal conjugate vaccine in adults 18 to 64 years old with medical conditions and other factors that increase risk of pneumococcal disease. Human Vaccines & Immunotherapeutics. 18(6). 2126253–2126253. 2 indexed citations
12.
Fitzpatrick, David, Daniel A. Scott, Ingrid L. Scully, et al.. (2021). A randomized phase 1 study of the safety and immunogenicity of 2 novel pneumococcal conjugate vaccines in healthy Japanese adults in the United States. Human Vaccines & Immunotherapeutics. 17(7). 2249–2256. 9 indexed citations
13.
14.
Lawrence, Jody, Nicholas Kitchin, Annaliesa S. Anderson, et al.. (2021). Safety and immunogenicity of different Clostridioides (Clostridium) difficile vaccine formulations in two early phase randomized studies of healthy adults aged 50–85 years. Vaccine. 39(40). 5991–6003. 7 indexed citations
15.
Essink, Brandon, Charu Sabharwal, Xia Xu, et al.. (2020). 3. Phase 3 Pivotal Evaluation of 20-valent Pneumococcal Conjugate Vaccine (PCV20) Safety, Tolerability, and Immunologic Noninferiority in Participants 18 Years and Older. Open Forum Infectious Diseases. 7(Supplement_1). S2–S2. 10 indexed citations
16.
17.
18.
Pasquier, Florence, Carl Sadowsky, Yahong Peng, et al.. (2016). Two Phase 2 Multiple Ascending–Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer’s Disease. Journal of Alzheimer s Disease. 51(4). 1131–1143. 77 indexed citations
19.
Zhi-gang, Zhao, Hongli Zhou, Yahong Peng, et al.. (2014). Expression and significance of plasma 3-NT and ox-LDL in patients with Alzheimer's disease. Genetics and Molecular Research. 13(4). 8428–8435. 16 indexed citations
20.
Sevigny, Jeffrey, Yahong Peng, Lian Liu, & Christopher R. Lines. (2009). Review: Item Analysis of ADAS-Cog: Effect of Baseline Cognitive Impairment in a Clinical AD Trial. American Journal of Alzheimer s Disease & Other Dementias®. 25(2). 119–124. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruth Kandel Breakdown of academic impact, for papers by R. Risser Breakdown of academic impact, for papers by Anu Gupta Breakdown of academic impact, for papers by Albert M. Anderson Breakdown of academic impact, for papers by Marie Grill Breakdown of academic impact, for papers by Aryun Kim Breakdown of academic impact, for papers by Lawrence Ku Breakdown of academic impact, for papers by Gabriel Westman Breakdown of academic impact, for papers by Jianjun Wang
Rankless by CCL
2026